Drawing for CYTOGUIDE

USPTO serial 79076289

CYTOGUIDE

Reviewed by CopyMark Law Group

Reg. 3983427Status 404
Filing date
Status date
Registration date
Jun 28, 2011
Examiner
SHARMA, NAPOLEON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CYTOGUIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LEIGH ANN LINDQUIST

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2100 PENNSYLVANIA AVENUE, N.W.WASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific or research use; reagents for scientific research useSECTION 71 - CANCELLED—
005Pharmaceutical preparations for use in the treatment of blood disorders, cancer, heart and blood vessel disorders, hormonal disorders, immune disorders, inflammatory disorders and infections; veterinary preparations for use in the treatment of blood disorders, cancer, heart and blood vessel disorders, hormonal disorders, immune disorders, inflammatory disorders and infections; chemical pharmaceutical preparations for use in the treatment of blood disorders, cancer, heart and blood vessel disorders, hormonal disorders, immune disorders, inflammatory disorders and infections; diagnostic reagents for clinical or medical laboratory use; medical diagnostic reagents; clinical medical reagents; diagnostic preparations for clinical or medical laboratory use; proteins, polypeptides and nucleic acids for clinical and medical laboratory use for the treatment of blood disorders, cancer, heart and blood vessel disorders, hormonal disorders, immune disorders, inflammatory disorders and infectionsSECTION 71 - CANCELLED—
040Treatment of materials, namely, processing and transformation in the nature of production for a third party of polypeptides and pharmaceuticalsSECTION 71 - CANCELLED—
042Scientific research and laboratory research in the fields of biotechnology, biology, and biomedicine; research and development for new products for others; development of polypeptide and pharmaceutical products; biological testing in the form of in vitro and in vivo pre-clinical testing of pharmaceuticals and other disease remedies; biological testing in the form of in vitro and in vivo research of pharmaceuticals and other disease remediesSECTION 71 - CANCELLED—
045Patent exploitation, namely, licensing of intellectual propertySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 17, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 17, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 14, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 11, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 11, 2018INPCINVALIDATION PROCESSED—
Oct 2, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 2, 2018C71TCANCELLED SECTION 71—
Feb 24, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 12, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 12, 2011FIMPFINAL DISPOSITION PROCESSED—
Sep 28, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 28, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2011OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 25, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 25, 2011OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 12, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 24, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 24, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 8, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 8, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 22, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 19, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 19, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2010ALIEASSIGNED TO LIE—
Jun 30, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 29, 2010RFNTREFUSAL PROCESSED BY IB—
Jan 5, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 5, 2010RFRRREFUSAL PROCESSED BY MPU—
Jan 5, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 1, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 31, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2009DOCKASSIGNED TO EXAMINER—
Dec 30, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance